Bellevue Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-91,916
| Closed | -$1.21M | – | 150 |
|
|
2025
Q1 | $1.21M | Sell |
91,916
-5,984
| -6% | -$78.9K | 0.03% | 105 |
|
|
2024
Q4 | $1.55M | Sell |
97,900
-5,075
| -5% | -$80.1K | 0.03% | 110 |
|
|
2024
Q3 | $1.64M | Sell |
102,975
-13,665
| -12% | -$217K | 0.03% | 109 |
|
|
2024
Q2 | $1.78M | Sell |
116,640
-87,840
| -43% | -$1.34M | 0.03% | 112 |
|
|
2024
Q1 | $3M | Sell |
204,480
-100,020
| -33% | -$1.47M | 0.05% | 104 |
|
|
2023
Q4 | $4.24M | Sell |
304,500
-96,500
| -24% | -$1.34M | 0.06% | 98 |
|
|
2023
Q3 | $5.41M | Sell |
401,000
-57,500
| -13% | -$776K | 0.09% | 100 |
|
|
2023
Q2 | $5.79M | Sell |
458,500
-59,000
| -11% | -$745K | 0.08% | 101 |
|
|
2023
Q1 | $5.89M | Sell |
517,500
-110,000
| -18% | -$1.25M | 0.09% | 100 |
|
|
2022
Q4 | $6.43M | Buy |
627,500
+565,500
| +912% | +$5.8M | 0.09% | 105 |
|
|
2022
Q3 | $664K | Hold |
62,000
| – | – | 0.01% | 143 |
|
|
2022
Q2 | $687K | Buy |
62,000
+19,500
| +46% | +$216K | 0.01% | 143 |
|
|
2022
Q1 | $474K | Hold |
42,500
| – | – | 0.01% | 157 |
|
|
2021
Q4 | $556K | Hold |
42,500
| – | – | 0.01% | 160 |
|
|
2021
Q3 | $554K | Hold |
42,500
| – | – | 0.01% | 162 |
|
|
2021
Q2 | $625K | Hold |
42,500
| – | – | 0.01% | 153 |
|
|
2021
Q1 | $522K | Hold |
42,500
| – | – | 0.01% | 157 |
|
|
2020
Q4 | $606K | Hold |
42,500
| – | – | 0.01% | 163 |
|
|
2020
Q3 | $591K | Sell |
42,500
-142,500
| -77% | -$1.98M | 0.01% | 163 |
|
|
2020
Q2 | $1.96M | Buy |
+185,000
| New | +$1.96M | 0.03% | 136 |
|